Carson Wealth (CWM LLC)
MRNA icon

Carson Wealth (CWM LLC)’s Moderna MRNA Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.7M Sell
386,906
-2,393
-0.6% -$112K 0.05% 336
2025
Q4 		$11.5M Sell
389,299
-1,034
-0.3% -$28.1K 0.03% 472
2025
Q3 		$10.1M Buy
390,333
+130,200
+50% +$3.63M 0.03% 469
2025
Q2 		$7.18M Sell
260,133
-866
-0.3% -$22.8K 0.03% 488
2025
Q1 		$7.4M Buy
260,999
+28,831
+12% +$1.02M 0.03% 421
2024
Q4 		$9.65M Buy
232,168
+86,978
+60% +$4.16M 0.04% 331
2024
Q3 		$9.7M Sell
145,190
-24,084
-14% -$2.21M 0.04% 317
2024
Q2 		$20.1M Buy
169,274
+48,141
+40% +$6.09M 0.09% 199
2024
Q1 		$12.9M Buy
121,133
+2,798
+2% +$282K 0.06% 252
2023
Q4 		$11.8M Buy
118,335
+25,209
+27% +$2.12M 0.06% 252
2023
Q3 		$9.62M Buy
93,126
+85,694
+1,153% +$9.56M 0.06% 247
2023
Q2 		$903K Sell
7,432
-1,580
-18% -$211K 0.01% 750
2023
Q1 		$1.38M Buy
9,012
+4,257
+90% +$702K 0.01% 565
2022
Q4 		$854K Buy
4,755
+1,145
+32% +$187K 0.01% 661
2022
Q3 		$427K Buy
3,610
+41
+1% +$6.22K ﹤0.01% 798
2022
Q2 		$510K Sell
3,569
-3,215
-47% -$460K ﹤0.01% 727
2022
Q1 		$1.17M Buy
6,784
+3,595
+113% +$605K 0.01% 523
2021
Q4 		$810K Buy
+3,189
New +$932K 0.01% 622
2021
Q2 		$804K Hold
3,423
– – 0.01% 602
2021
Q1 		$804K Hold
3,423
– – 0.01% 602
2020
Q4 		$804K Hold
3,423
– – 0.01% 602
2020
Q3 		$804K Hold
3,423
– – 0.01% 602
2020
Q2 		$804K Hold
3,423
– – 0.01% 602
2020
Q1 		$804K Hold
3,423
– – 0.01% 602
2019
Q4 		$804K Hold
3,423
– – 0.01% 602
2019
Q3 		$804K Hold
3,423
– – 0.01% 602
2019
Q2 		$804K Hold
3,423
– – 0.01% 602
2019
Q1 		$804K Buy
+3,423
New +$63.5K 0.01% 602

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Carson Wealth (CWM LLC)'s MRNA Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Moderna (MRNA) stake by 0.61% in Q1 2026, selling an estimated $112K and leaving 386,906 shares worth $19.7M. The position accounts for 0.05% of the portfolio, ranked #336.

Carson Wealth (CWM LLC) first reported a position in MRNA in Q1 2019 and has held it in 28 quarters since. The position peaked at $20.1M in Q2 2024. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Carson Wealth (CWM LLC) held 386,906 shares of Moderna worth $19.7M as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 2,393 Moderna shares in Q1 2026, an estimated $112K.
  • Moderna made up 0.05% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #336 holding.
  • Carson Wealth (CWM LLC) first reported a position in Moderna in Q1 2019 and has held it in 28 quarters since.
  • Carson Wealth (CWM LLC)'s Moderna position peaked at $20.1M in Q2 2024.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.